This publication contains a revised global strategy for dealing with H5N1 highly pathogenic avian influenza (HPAI) developed by the FAO and the World Organization for Animal Health (OIE), in collaboration with WHO, and drawing on experiences and lessons learned since the panzootic started in late 2003. This third revision sets out a long-term vision and goals, identifies priorities and strategic approaches, and proposes actions at national, regional and global levels to control and ultimately eradicate the disease.

Since then, most affected countries have eliminated the disease.

When, in late 2011, it became public knowledge that two research groups had submitted for publication manuscripts that reported on their work on mammalian transmissibility of a lethal H5N1 avian influenza strain, the information caused an international debate about the appropriateness and communication of the researchers' work, the risks associated with the work, partial or complete censorship of scientific publications, and dual-use research of concern in general. Recognizing that the H5N1 research is only the most recent scientific activity subject to widespread attention due to safety and security concerns, on May 1, 2012, the National Research Council's Committee on Science, Technology and Law, in conjunction with the Board on Life Sciences and the Institute of Medicine's Forum on Microbial Threats, convened a one-day public workshop for the purposes of 1) discussing the H5N1 controversy; 2) considering responses by the National Institute of Allergy and Infectious Diseases (NIAID), which had funded this research, the World Health Organization, the U.S. National Science Advisory Board for Biosecurity (NSABB), scientific publishers, and members of the international research community; and 3) providing a forum wherein the concerns and interests of the broader community of stakeholders, including policy makers, biosafety and biosecurity experts, non-governmental organizations, international organizations, and the general public might be articulated. Perspectives on Research with H5N1 Avian Influenza: Scientific Enquiry, Communication, Controversy summarizes the proceedings of the workshop.

Avian Influenza provides the first comprehensive guide covering the full spectrum of this complex and increasingly high-profile disease, its history and its treatment and control. All aspects of avian influenza are dealt with in depth, systematically covering biology, virology, diagnostics, ecology, epidemiology, clinical medicine, and the control. The book fuses coverage of the latest discoveries in the basic sciences with a practical approach to dealing with the disease in a clinical setting, and providing instruction and guidance for veterinarians and government animal health officials encountering this disease in the field. Avian Influenza provides the reader with a global perspective, bringing together chapters written by leading animal health researchers and veterinarians with significant experience working with this disease. Providing a summary and synthesis of important data and research on this virus, its impact on both wild and domesticated birds, and approaches to controlling the spread of the disease, Avian Influenza will be an invaluable resource for all veterinarians, scientists, animal health professionals, and public health officials dealing with this virus. * Covers full range of topics within avian influenza in one comprehensive and authoritative text * Provides a summarization of peer-reviewed and empirical data on avian influenza viruses, the infection and diseases they cause * Discusses strategies used in control of the disease * Leading experts are drawn together to provide an international and multi-disciplinary perspective * Fuses latest developments in basic scientific research with practical guidance on management of the disease

Some avian influenza viruses can infect humans, cause disease, and even result in deaths. This book comprehensively and systematically presents the theory, diagnosis and clinical treatment of typical avian influenza viruses in human. The first chapters introduce the ethiology, epidemiology, clinical diagnosis and treatment of human avian influenza and complications. The following chapters include overview, extensive images, differential diagnosis and clinical cases of H7N9, H5N1, H5N6, H10N8, H9N2 and H7N4 avian influenza. Written by practitioners directly involved in the prevention and clinical treatment of human avian influenza, it will be an invaluable aid for practitioners in centers for infectious disease control and prevention, hospitals, and academic institutions to improve prevention, diagnosis and treatment of avian influenza in human.

Avian Influenza poses a looming threat for human and animal health. The old paradigm was that the disease in waterfowl, poultry, pigs and man was caused by separate viruses that stayed within their own niche. Deadly outbreaks have shattered this view. This timely reference examines such sensitive issues as regulation of low pathogenic and high pathogenic AI, surveillance of waterfowl, live bird markets, and outbreak control in densely populated areas.

In March and early April 2009, a new, swine-origin 2009-H1N1 influenza A virus emerged in Mexico and the United States. During the first few weeks of surveillance, the virus spread by human-to-human transmission worldwide to over 30 countries. On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the novel influenza A (H1N1) virus. By October 30, 2009, the H1N1 influenza A had spread to 191 countries and resulted in 5,700 fatalities. A national emergency was declared in the United States and the swine flu joined SARS and the avian flu as pandemics of the 21st century. Vaccination is currently available, but in limited supply, and with a 60 percent effectiveness rate against the virus. The story of how this new influenza virus spread out of Mexico to other parts of North America and then on to Europe, the Far East, and now Australia and the Pacific Rim countries has its origins in the global interconnectedness of travel, trade, and tourism. Given the rapid spread of the virus, the international scientific, public health, security, and policy communities had to mobilize quickly to characterize this unique virus and address its potential effects. The World Health Organization and Centers for Disease Control have played critical roles in the surveillance, detection and responses to the H1N1 virus. The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions aimed to examine the evolutionary origins of the H1N1 virus and evaluate its potential public health and socioeconomic consequences, while monitoring and mitigating the impact of a fast-moving pandemic. The rapporteurs for this workshop reported on the need for increased and geographically robust global influenza vaccine production capacities; enhanced and sustained interpandemic demand for seasonal influenza vaccines; clear "triggers" for pandemic alert levels; and accelerated research collaboration on new vaccine manufacturing techniques. This book will be an essential guide for healthcare professionals, policymakers, drug manufacturers and investigators.